Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315) and Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. (“NJCTTQ”) announced that NTB003 (formerly BCG009), a co-developed injectable drug candidate, has received the Investigational New Drug (IND) approval from the National Medical Products Administration (NMPA). The approved indication is Thyroid Eye Disease (TED). About NTB003 Injection NTB003 is a second-generation full...

European fintech Token.io has today announced that HSBC has become a strategic investor, signaling their continued collaboration and focus on delivering cutting-edge payment solutions. As revealed at Money2020 Europe, HSBC’s investment marks an important milestone for Token.io, a company specialising in account-to-account (A2A) payment infrastructure, which has partnered with the bank since 2019 to power its successful HSBC Open Payments solution. ...